30
Participants
Start Date
November 15, 2024
Primary Completion Date
November 15, 2027
Study Completion Date
November 15, 2028
GPC3-CART cells
"Phase 1: Dose escalation (3+3): Dose 1 (1 × 10\^6 cells/kg) with or without FC regimen, Dose 2 (3 × 10\^6 cells/kg), Dose 3 (6 × 10\^6 cells/kg).~Phase 2: Dose at RP2D."
Fludarabine Phosphate for Injection
Administered intravenously at a dose of 20-30 mg/m²/day on days -5, -4, and -3.
Cyclophosphamide for Injection
Administered intravenously at a dose of 300-500 mg/m²/day on days -5, -4, and -3.
Biotherapeutic Department of Chinese PLA General Hospital, Beijing
Chinese PLA General Hospital
OTHER